Galapagos | GLPG - Current Liabilities

Stock Price
27.62
Daily Change
-0.10 -0.36%
Monthly
-1.36%
Yearly
15.66%
Q1 Forecast
27.05

Galapagos reported EUR152.86M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
argenx SE USD 1.04B 371.99M Jun/2025
AstraZeneca USD 30.62B 3.44B Dec/2025
Biogen USD 3.35B 59.4M Dec/2025
Genmab DKK 629M 127M Jun/2025
Gilead Sciences USD 11.81B 485M Dec/2025
GlaxoSmithKline GBP 21.39B 57M Dec/2025
GRIFOLS EUR 2.02B 135.85M Dec/2025
Hikma Pharmaceutical USD 1.45B 603M Dec/2025
Incyte USD 1.52B 176.44M Dec/2025
Merck EUR 9.04B 405M Dec/2025
Neurocrine Biosciences USD 743.4M 105.4M Dec/2025
Novartis USD 32B 286M Sep/2025
Roche Holding CHF 28B 421M Dec/2025
Sanofi EUR 28.35B 3.76B Dec/2025
UCB EUR 3.53B 731M Dec/2024
Vertex Pharmaceuticals USD 3.86B 614.1M Dec/2025